MyFinsight
Home
Blog
About
Contact
Maturities of marketable
securities
$29,000K
Proceeds from sale of
marketable securities
$26,342K
Proceeds from term loan
$15,000K
Proceeds from the
exercise of stock options
$25K
Net cash provided by
investing activities
$55,024K
Net cash provided by
financing activities
$14,862K
Canceled cashflow
$318K
Canceled cashflow
$163K
Increase (decrease) in
cash and cash...
$39,995K
Canceled cashflow
$29,891K
Purchases of property and
equipment
$318K
Stock-based compensation
expense
$1,193K
Non-cash operating lease
expense
$109K
Depreciation
$63K
Amortization of debt discount
and deferred...
$5K
Payments of issuance
costs associated with...
$163K
Net cash used in
operating activities
-$29,891K
Canceled cashflow
$1,370K
Net loss
-$26,869K
Accrued liabilities
-$2,464K
Accounts payable
-$1,113K
Prepaid expenses and
other current assets
$508K
Amortization and accretion of
premiums/discounts on marketable...
$237K
Operating lease liability
-$70K
Back
Back
Cash Flow
Avalyn Pharma Inc. (AVLN)
Avalyn Pharma Inc. (AVLN)
source: myfinsight.com